{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:58:36Z","timestamp":1790985516019,"version":"4.1.0"},"reference-count":128,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPR"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Erythema infectiosum occurs worldwide. School-aged children are most often affected. Since the diagnosis is mainly clinical, physicians should be well-versed in the clini-cal manifestations of erythema infectiosum to avoid misdiagnosis, unnecessary investigations, and mismanagement of the disease.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The purpose of this article is to familiarize physicians with the wide spectrum of clinical manifestations and complications of erythema infectiosum associated with parvovirus B19 infection.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A search was conducted in July 2022 in PubMed Clinical Queries using the key terms \"Erythema infectiosum\" OR \u201cFifth disease\u201d OR \u201cSlapped cheek disease\u201d OR \u201cParvovirus B19\u201d. The search strategy included all clinical trials, observational studies, and reviews published within the past 10 years. Only papers published in the English literature were included in this review. The information retrieved from the above search was used in the compilation of the present article.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Erythema infectiosum is a common exanthematous illness of childhood caused by parvovirus B19. Parvovirus B19 spreads mainly by respiratory tract secretions and, to a lesser extent, the saliva of infected individuals. Children between 4 and 10 years of age are most often affected. The incubation period is usually 4 to 14 days. Prodromal symptoms are usually mild and consist of low-grade fever, headache, malaise, and myalgia. The rash typically evolves in 3 stages. The initial stage is an erythematous rash on the cheeks, with a characteristic \u201cslapped cheek\u201d appearance. In the second stage, the rash spreads concurrently or quickly to the trunk, extremities, and buttocks as diffuse macular erythema. The rash tends to be more intense on extensor surfaces. The palms and soles are typically spared. Central clearing of the rash results in a characteristic lacy or reticulated appearance. The rash usually resolves spontaneously within three weeks without sequelae. The third stage is characterized by evanescence and recrudescence. In adults, the rash is less pronounced than that in children and is often atypical. Only approximately 20% of affected adults have an erythematous rash on the face. In adults, the rash is more frequently found on the legs, followed by the trunk, and arms. A reticulated or lacy erythema is noted in 80% of cases which helps to distinguish erythema infectiosum from other exanthems. Pruritus is noted in approximately 50% of cases. The diagnosis is mainly clinical. The many manifestations of parvovirus B19 infection can pose a diagnostic challenge even to the best diagnostician. Complications include arthritis, arthralgia, and transient aplastic crisis. In most cases, treatment is symptomatic and supportive. When parvovirus B19 infection occurs in pregnant women, hydrops fetalis becomes a real concern.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Erythema infectiosum, the most common clinical manifestation of parvovirus B19 in-fection, is characterized by a \u201cslapped cheek\u201d appearance on the face and lacy exanthem on the trunk and extremities. Parvovirus B19 infection is associated with a wide spectrum of clinical mani-festations. Physicians should be aware of potential complications and conditions associated with parvovirus B19 infection, especially in individuals who are immunocompromised, chronically ane-mic, or pregnant.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573396320666230428104619","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T06:27:29Z","timestamp":1683095249000},"page":"462-471","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Erythema Infectiosum: A Narrative Review"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2254-6971","authenticated-orcid":true,"given":"Alexander K. C.","family":"Leung","sequence":"first","affiliation":[{"name":"Department of Pediatrics, The University of Calgary, Alberta Children\u2019s Hospital, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7808-3369","authenticated-orcid":true,"given":"Joseph M.","family":"Lam","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Department of Dermatology and Skin Sciences, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Barankin","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Toronto Dermatology Centre, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1984-7960","authenticated-orcid":true,"given":"Kin Fon","family":"Leong","sequence":"additional","affiliation":[{"name":"Pediatric Institute, Kuala Lumpur General Hospital, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6682-5529","authenticated-orcid":true,"given":"Kam Lun","family":"Hon","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, The Chinese University of Hong Kong, China"},{"name":"Department of Paediatrics and Adolescent Medicine, Hong Kong Children\u2019s Hospital, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","author":"Macri A.","year":"2022","unstructured":"Macri A.; Crane J.S.;  ParvovirusesStatPearls  2022","journal-title":"ParvovirusesStatPearls"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1056\/NEJMicm1807156","volume":"379","author":"Mende M.","year":"2018","unstructured":"Mende M.; Sockel K.; Parvovirus B19 Infection. N Engl J Med  2018,379(24),2361","journal-title":"N Engl J Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1056\/NEJMra030840","volume":"350","author":"Young N.S.","year":"2004","unstructured":"Young N.S.; Brown K.E.; Parvovirus B19. N Engl J Med  2004,350(6),586-597","journal-title":"N Engl J Med"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1053\/hp.2000.6714","volume":"31","author":"Magro C.M.","year":"2000","unstructured":"Magro C.M.; Dawood M.R.; Crowson A.N.; The cutaneous manifestations of humanparvovirus B19 infection. Hum Pathol  2000,31(4),488-497","journal-title":"Hum Pathol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4149\/av_2014_03_199","volume":"58","author":"Rogo L.D.","year":"2014","unstructured":"Rogo L.D.; Mokhtari-Azad T.; Kabir M.H.; Rezaei F.; Human parvovirus B19: A review. Acta Virol  2014,58(3),199-213","journal-title":"Acta Virol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"366","DOI":"10.25270\/cfp.2006.06.00001","volume":"5","author":"Leung A.K.","year":"2006","unstructured":"Leung A.K.; Robson W.L.; Erythema infectiosum (fifth disease). Consultant Pediatrician  2006,5,366-370","journal-title":"Consultant Pediatrician"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/S0140-6736(75)91074-0","volume":"1","author":"Cossart Y.E.","year":"1975","unstructured":"Cossart Y.E.; Field A.M.; Cant B.; Widdows D.; Parvovirus-like particles in human sera. Lancet  1975,1(7898),72-73","journal-title":"Lancet"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1128\/microbiolspec.DMIH2-0008-2015","volume":"4","author":"Landry M.L.","year":"2016","unstructured":"Landry M.L.; Parvovirus B19. Microbiol Spectr  2016,4(3),4-34","journal-title":"Microbiol Spectr"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/S0140-6736(83)92152-9","volume":"321","author":"Anderson M.J.","year":"1983","unstructured":"Anderson M.J.; Jones S.E.; Fisher-Hoch S.P.; Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet  1983,321(8338),1378","journal-title":"Lancet"},{"key":"ref=10","author":"Jordan J.A.","year":"2022","unstructured":"Jordan J.A.;  Treatment and prevention of parvovirus B19 infection  2022","journal-title":"Treatment and prevention of parvovirus B19 infection"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/00001432-200106000-00016","volume":"14","author":"Koch W.C.","year":"2001","unstructured":"Koch W.C.; Fifth (human parvovirus) and sixth (herpesvirus 6) diseases. Curr Opin Infect Dis  2001,14(3),343-356","journal-title":"Curr Opin Infect Dis"},{"key":"ref=12","author":"Jordan JA","unstructured":"Jordan JA; Virology, epidemiology, and pathogenesis of parvovirus B19 infection. UpToDate","journal-title":"UpToDate"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/jmv.1890430214","volume":"43","author":"Schwarz T.F.","year":"1994","unstructured":"Schwarz T.F.; Wiersbitzky S.; Pambor M.; Detection of parvovirus B19 in a skin biopsy of a patient with erythema infectiosum. J Med Virol  1994,43(2),171-174","journal-title":"J Med Virol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"8227","DOI":"10.1073\/pnas.95.14.8227","volume":"95","author":"Takahashi Y.","year":"1998","unstructured":"Takahashi Y.; Murai C.; Shibata S.; Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci USA  1998,95(14),8227-8232","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/infdis\/152.2.257","volume":"152","author":"Anderson M.J.","year":"1985","unstructured":"Anderson M.J.; Higgins P.G.; Davis L.R.; Experimental parvoviral infection in humans. J Infect Dis  1985,152(2),257-265","journal-title":"J Infect Dis"},{"key":"ref=16","author":"Riley LE","unstructured":"Riley LE; Fernandes CJ; Parvovirus B19 infection during pregnancy. UpToDate","journal-title":"UpToDate"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1525-1470.2005.00109.x","volume":"22","author":"Huerta-Brogeras M.","year":"2005","unstructured":"Huerta-Brogeras M.; Avil\u00e9s Izquierdo J.A.; Hernanz Hermosa J.M.; L\u00e1zaro-Ochaita P.; Longo-Imedio M.I.; Petechial exanthem in \u201cbathing trunk\u201d distribution caused by parvovirus B19 infection. Pediatr Dermatol  2005,22(5),430-433","journal-title":"Pediatr Dermatol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1182\/blood.V63.4.729.729","volume":"63","author":"Young N.","year":"1984","unstructured":"Young N.; Mortimer P.; Viruses and bone marrow failure. Blood  1984,63(4),729-737","journal-title":"Blood"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1126\/science.8211117","volume":"262","author":"Brown K.E.","year":"1993","unstructured":"Brown K.E.; Anderson S.M.; Young N.S.; Erythrocyte P antigen: Cellular receptor for B19 parvovirus. Science  1993,262(5130),114-117","journal-title":"Science"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1053\/plac.1998.0353","volume":"20","author":"Jordan J.A.","year":"1999","unstructured":"Jordan J.A.; DeLoia J.A.; Globoside expression within the human placenta. Placenta  1999,20(1),103-108","journal-title":"Placenta"},{"key":"ref=21","first-page":"589","volume":"32","author":"Frydenberg A.","year":"2003","unstructured":"Frydenberg A.; Starr M.; Slapped cheek disease. How it affects children and pregnant women. Aust Fam Physician  2003,32(8),589-592","journal-title":"Aust Fam Physician"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0002-9378(96)70370-8","volume":"174","author":"Jordan J.A.","year":"1996","unstructured":"Jordan J.A.; Identification of human parvovirus B19 infection in idiopathic nonimmune hydrops fetalis. Am J Obstet Gynecol  1996,174(1),37-42","journal-title":"Am J Obstet Gynecol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/01720610-200906000-00009","volume":"22","author":"Mandel E.D.","year":"2009","unstructured":"Mandel E.D.; Erythema infectiosum: Recognizing the many faces of fifth disease. JAAPA  2009,22(6),42-46","journal-title":"JAAPA"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1128\/jcm.31.2.323-328.1993","volume":"31","author":"McOmish F.","year":"1993","unstructured":"McOmish F.; Yap P.L.; Jordan A.; Hart H.; Cohen B.J.; Simmonds P.; Detection of parvovirus B19 in donated blood: A model system for screening by polymerase chain reaction. J Clin Microbiol  1993,31(2),323-328","journal-title":"J Clin Microbiol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1046\/j.1365-2141.1996.d01-1679.x","volume":"93","author":"Saldanha J.","year":"1996","unstructured":"Saldanha J.; Minor P.; Detection of human parvovirus B19 DNA in plasma pools and blood products derived from these pools: Implica-tions for efficiency and consistency of removal of B19 DNA during manufacture. Br J Haematol  1996,93(3),714-719","journal-title":"Br J Haematol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/120347540500900401","volume":"9","author":"Vafaie J.","year":"2005","unstructured":"Vafaie J.; Schwartz R.A.; Erythema Infectiosum. J Cutan Med Surg  2005,9(4),159-161","journal-title":"J Cutan Med Surg"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/j.1365-2141.1995.tb05427.x","volume":"91","author":"Yoto Y.","year":"1995","unstructured":"Yoto Y.; Kudoh T.; Haseyama K.; Incidence of human parvovirus B19 DNA detection in blood donors. Br J Haematol  1995,91(4),1017-1018","journal-title":"Br J Haematol"},{"key":"ref=28","author":"Kostolansky S.","year":"2021","unstructured":"Kostolansky S.; Waymack J.R.;  Erythema infectiosum  2021","journal-title":"Erythema infectiosum"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.pop.2015.08.006","volume":"42","author":"Ramdass P.","year":"2015","unstructured":"Ramdass P.; Mullick S.; Farber H.F.; Viral skin diseases. Prim Care  2015,42(4),517-567","journal-title":"Prim Care"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"12742990","DOI":"10.3389\/fimmu.2021.742990","author":"Luo J.","year":"2021","unstructured":"Luo J.; Zhang J.; Lai W.; Disseminated human parvovirus B19 infection induced multiple organ dysfunction syndrome in an adult patient with alcoholic hepatitis complicated by hemolytic anemia: A case report and literature review. Front Immunol  2021,12742990","journal-title":"Front Immunol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.2298\/VSP110607026P","volume":"70","author":"Pr\u0107i\u0107 S.","year":"2013","unstructured":"Pr\u0107i\u0107 S.; Gajinov Z.; Zrni\u0107 B.; Radulovi\u0107 A.; Mati\u0107 M.; Djuran V.; Epidemiological and clinical features of erythema infectiosum in children in Novi Sad from 2000 to 2009. Vojnosanit Pregl  2013,70(12),1081-1084","journal-title":"Vojnosanit Pregl"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1099\/00222615-25-2-151","volume":"25","author":"Cohen B.J.","year":"1988","unstructured":"Cohen B.J.; Buckley M.M.; The prevalence of antibody to human parvovirus B 19 in England and Wales. J Med Microbiol  1988,25(2),151-153","journal-title":"J Med Microbiol"},{"key":"ref=33","first-page":"562","author":"Kimberlin D.W.","year":"2022","unstructured":"Kimberlin D.W.; Barnett E.D.; Lynfield R.; Swayer M.H.; American Academy of Pediatrics. Parvovirus B19 (erythema infectiosum, fifth disease).Red Book: 2021-2024 Report of the Committee on Infectious Diseases. 32nd ed.  2022,562-566"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1001\/archinte.1989.00390050111022","volume":"149","author":"Woolf A.D.","year":"1989","unstructured":"Woolf A.D.; Campion G.V.; Chishick A.; Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med  1989,149(5),1153-1156","journal-title":"Arch Intern Med"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1001\/jama.1990.03440150069028","volume":"263","author":"Gillespie S.M.","year":"1990","unstructured":"Gillespie S.M.; Cartter M.L.; Asch S.; Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum. JAMA  1990,263(15),2061-2065","journal-title":"JAMA"},{"key":"ref=36","author":"Jordan JA","unstructured":"Jordan JA; Clinical manifestations and diagnosis of parvovirus B19 infection. UpToDate","journal-title":"UpToDate"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1503\/cmaj.045293","volume":"172","author":"Weir E.","year":"2005","unstructured":"Weir E.; Parvovirus B19 infection: Fifth disease and more. CMAJ  2005,172(6),743","journal-title":"CMAJ"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1365-4362.1995.tb03594.x","volume":"34","author":"Veraldi S.","year":"1995","unstructured":"Veraldi S.; Rizzitelli G.; Erythematous exanthem associated with primary infection by human parvovirus B19. Int J Dermatol  1995,34(2),119","journal-title":"Int J Dermatol"},{"key":"ref=39","first-page":"338","volume":"48","author":"Sachan D.","year":"2011","unstructured":"Sachan D.; Erythema infectiosum rash. Indian Pediatr  2011,48(4),338","journal-title":"Indian Pediatr"},{"key":"ref=40","first-page":"211","volume":"92","author":"Allmon A.","year":"2015","unstructured":"Allmon A.; Deane K.; Martin K.L.; Common skin rashes in children. Am Fam Physician  2015,92(3),211-216","journal-title":"Am Fam Physician"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jaad.2014.02.044","volume":"71","author":"Mage V.","year":"2014","unstructured":"Mage V.; Lipsker D.; Barbarot S.; Different patterns of skin manifestations associated with parvovirus B19 primary infection in adults. J Am Acad Dermatol  2014,71(1),62-69","journal-title":"J Am Acad Dermatol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jcv.2016.09.004","volume":"84","author":"Molenaar-de Backer M.W.A.","year":"2016","unstructured":"Molenaar-de Backer M.W.A.; Russcher A.; Kroes A.C.M.; Koppelman M.H.G.M.; Lanfermeijer M.; Zaaijer H.L.; Detection of parvovirus B19 DNA in blood: Viruses or DNA remnants? J Clin Virol  2016,84,19-23","journal-title":"J Clin Virol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/0140-6736(93)91145-C","volume":"341","author":"Serjeant G.R.","year":"1993","unstructured":"Serjeant G.R.; Serjeant B.E.; Thomas P.W.; Anderson M.J.; Patou G.; Pattison J.R.; Human parvovirus infection in homozygous sickle cell disease. Lancet  1993,341(8855),1237-1240","journal-title":"Lancet"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/j.1468-3083.2010.03772.x","volume":"25","author":"Alc\u00e1ntara Gonz\u00e1lez J.","year":"2011","unstructured":"Alc\u00e1ntara Gonz\u00e1lez J.; Boixeda P.; Truchuelo D\u00edez M.T.; Fleta As\u00edn B.; Keratosis pilaris rubra and keratosis pilaris atrophicans faciei treated with pulsed dye laser: Report of 10 cases. J Eur Acad Dermatol Venereol  2011,25(6),710-714","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5070\/D31K03Z1TV","volume":"7","author":"Alexiades-Armenakas M.","year":"2001","unstructured":"Alexiades-Armenakas M.; Tumid lupus erythematosus. Dermatol Online J  2001,7(2),14","journal-title":"Dermatol Online J"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/pde.14486","volume":"38","author":"Arias A.F.","year":"2021","unstructured":"Arias A.F.; Diaz A.; Erdem G.; Tinea faciei caused by Trichophyton benhamiae in a child. Pediatr Dermatol  2021,38(2),520-521","journal-title":"Pediatr Dermatol"},{"key":"ref=47","author":"Callen J.","year":"2023","unstructured":"Callen J.; Approach to the patient with facial erythema. UpToDate  2023","journal-title":"UpToDate"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1001\/jama.2018.17288","volume":"320","author":"Cox B.","year":"2018","unstructured":"Cox B.; Levent F.; Hand, foot, and mouth disease. JAMA  2018,320(23),2492","journal-title":"JAMA"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10096-018-3206-x","volume":"37","author":"Esposito S.","year":"2018","unstructured":"Esposito S.; Principi N.; Hand, foot and mouth disease: Current knowledge on clinical manifestations, epidemiology, aetiology and prevention. Eur J Clin Microbiol Infect Dis  2018,37(3),391-398","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/0738-081X(93)90067-M","volume":"11","author":"Grosshans E.M.","year":"1993","unstructured":"Grosshans E.M.; The red face: Erysipelas. Clin Dermatol  1993,11(2),307-313","journal-title":"Clin Dermatol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.autrev.2015.11.014","volume":"15","author":"Jin H.","year":"2016","unstructured":"Jin H.; Zhang G.; Zhou Y.; Chang C.; Lu Q.; Old lines tell new tales: Blaschko linear lupus erythematosis. Autoimmun Rev  2016,15(4),291-306","journal-title":"Autoimmun Rev"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1046\/j.1365-4362.2003.01699_1.x","volume":"42","author":"Leung A.K.C.","year":"2003","unstructured":"Leung A.K.C.; Rafaat M.; Eruption associated with amoxicillin in a patient with infectious mononucleosis. Int J Dermatol  2003,42(7),553-555","journal-title":"Int J Dermatol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/BF02850032","volume":"21","author":"Leung A.K.C.","year":"2004","unstructured":"Leung A.K.C.; Kellner J.D.; Group A \u03b2-hemolytic streptococcal pharyngitis in children. Adv Ther  2004,21(5),277-287","journal-title":"Adv Ther"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"593","DOI":"10.12809\/hkmj187275","volume":"24","author":"Leung T.N.H.","year":"2018","unstructured":"Leung T.N.H.; Hon K.L.; Leung A.K.C.; Group A.; Group A.; Streptococcus disease in Hong Kong children: An overview. Hong Kong Med J  2018,24(6),593-601","journal-title":"Hong Kong Med J"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"512","DOI":"10.12809\/hkmj187470","volume":"24","author":"Leung A.K.C.","year":"2018","unstructured":"Leung A.K.C.; Hon K.L.; Leong K.F.; Sergi C.M.; Measles: A disease often forgotten but not gone. Hong Kong Med J  2018,24(5),512-520","journal-title":"Hong Kong Med J"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"134","DOI":"10.12809\/hkmj187785","volume":"25","author":"Leung A.K.C.","year":"2019","unstructured":"Leung A.K.C.; Hon K.L.; Leong K.F.; Rubella (German measles) revisited. Hong Kong Med J  2019,25(2),134-141","journal-title":"Hong Kong Med J"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2174\/1573396317666210426105045","volume":"17","author":"Leung A.K.C.","year":"2021","unstructured":"Leung A.K.C.; Lam J.M.; Alobaida S.; Leong K.F.; Wong A.H.C.; Juvenile dermatomyositis: Advances in pathogenesis, assessment, and management. Curr Pediatr Rev  2021,17(4),273-287","journal-title":"Curr Pediatr Rev"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1093\/pch\/pxab113","volume":"27","author":"Leung A.K.C.","year":"2022","unstructured":"Leung A.K.C.; Leong K.F.; Lam J.M.; Asymptomatic linear erythematous plaques following the lines of Blaschko on the cheek. Paediatr Child Health  2022,27(3),136-137","journal-title":"Paediatr Child Health"},{"key":"ref=59","author":"Lopez FA","unstructured":"Lopez FA; Sanders CV; Fever and rash in the immunocompetent patient. UpToDate","journal-title":"UpToDate"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7573\/dic.2021-11-1","volume":"11","author":"Maliyar K.","year":"2022","unstructured":"Maliyar K.; Abdulla S.J.; Dermatology: How to manage rosacea in skin of colour. Drugs Context  2022,11,1-9","journal-title":"Drugs Context"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jpeds.2021.08.029","volume":"239","author":"Papazoglou A.","year":"2021","unstructured":"Papazoglou A.; Mantadakis E.; Fig tree leaves phytophotodermatitis. J Pediatr  2021,239,244-245","journal-title":"J Pediatr"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/01.JAA.0000431514.97948.fd","volume":"26","author":"Rizzolo D.","year":"2013","unstructured":"Rizzolo D.; McWeeney M.; A toddler\u2019s fever and rash. JAAPA  2013,26(7),11-12","journal-title":"JAAPA"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2174\/1573396317666210224144416","volume":"17","author":"Tsang V.","year":"2021","unstructured":"Tsang V.; Leung A.K.C.; Lam J.M.; Cutaneous lupus erythematosus in children. Curr Pediatr Rev  2021,17(2),103-110","journal-title":"Curr Pediatr Rev"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.medcle.2022.04.008","volume":"159","author":"Cervero R.","year":"2022","unstructured":"Cervero R.; Systemic lupus erythematosus criteria nowadays. Med Clin  2022,159(4),187-188","journal-title":"Med Clin"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1146\/annurev-med-043021-032611","volume":"74","author":"Lazar S.","year":"2022","unstructured":"Lazar S.; Kahlenberg J.M.; Systemic Lupus erythematosus: New diagnostic and therapeutic approaches. Annu Rev Med  2022,74,339-352","journal-title":"Annu Rev Med"},{"key":"ref=66","author":"Rixe N.","year":"2022","unstructured":"Rixe N.; Tavarez M.M.;  Serum sickness StatPearls  2022","journal-title":"Serum sickness StatPearls"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"e05900","DOI":"10.1002\/ccr3.5900","volume":"10","author":"Sahba S.","year":"2022","unstructured":"Sahba S.; Huurnink A.; Van den Berg J.M.; Tuitert B.; Vastert S.J.; Ten Tusscher G.W.; Systemic Juvenile Idiopathic Arthritis in two children; case report on clinical course, challenges in diagnosis and the role of FDG\u2010PET\/CT\u2010scan. Clin Case Rep  2022,10(6),e05900","journal-title":"Clin Case Rep"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/pde.15029","volume":"39","author":"Tjahjono L.","year":"2022","unstructured":"Tjahjono L.; Czaja R.; Lalor L.; Hasse-Rupp B.; Wanat K.A.; Persistent papules and plaques in systemic juvenile idiopathic arthritis. Pediatr Dermatol  2022,39(4),616-618","journal-title":"Pediatr Dermatol"},{"key":"ref=69","first-page":"373","volume":"75","author":"Servey J.T.","year":"2007","unstructured":"Servey J.T.; Reamy B.V.; Hodge J.; Clinical presentations of parvovirus B19 infection. Am Fam Physician  2007,75(3),373-376","journal-title":"Am Fam Physician"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1097\/RHU.0b013e31823abf1a","volume":"17","author":"Tello-Winniczuk N.","year":"2011","unstructured":"Tello-Winniczuk N.; D\u00edaz-Jouanen E.; D\u00edaz-Borj\u00f3n A.; Parvovirus B19-associated arthritis: Report on a community outbreak. J Clin Rheumatol  2011,17(8),449-450","journal-title":"J Clin Rheumatol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1099\/jmm.0.05485-0","volume":"53","author":"Corcoran A.","year":"2004","unstructured":"Corcoran A.; Doyle S.; Advances in the biology, diagnosis and host\u2013pathogen interactions of parvovirus B19. J Med Microbiol  2004,53(6),459-475","journal-title":"J Med Microbiol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"518","DOI":"10.4067\/s0716-10182018000500518","volume":"35","author":"Neely G.","year":"2018","unstructured":"Neely G.; Cabrera R.; Hojman L.; Parvovirus B19: A DNA virus associated with multiple cutaneous manifestations. Rev Chilena Infectol  2018,35(5),518-530","journal-title":"Rev Chilena Infectol"},{"key":"ref=73","first-page":"2444","volume":"27","author":"Scroggie D.A.","year":"2000","unstructured":"Scroggie D.A.; Carpenter M.T.; Cooper R.I.; Higgs J.B.; Parvovirus arthropathy outbreak in southwestern United States. J Rheumatol  2000,27(10),2444-2448","journal-title":"J Rheumatol"},{"key":"ref=74","author":"Tiwari V.","year":"2022","unstructured":"Tiwari V.; Bergman M.J.;  Viral arthritisStatPearls  2022","journal-title":"Viral arthritisStatPearls"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.4103\/jfmpc.jfmpc_25_19","volume":"8","author":"Alexander V.","year":"2019","unstructured":"Alexander V.; Das S.; Mangan A.; Iyadurai R.; Acute parvovirus B19 infection presenting as rheumatoid arthritis mimic. J Family Med Prim Care  2019,8(3),1257-1259","journal-title":"J Family Med Prim Care"},{"key":"ref=76","first-page":"576","volume":"16","author":"Speyer I.","year":"1998","unstructured":"Speyer I.; Breedveld F.C.; Dijkmans B.A.; Human parvovirus B19 infection is not followed by inflammatory joint disease during long term follow-up. A retrospective study of 54 patients. Clin Exp Rheumatol  1998,16(5),576-578","journal-title":"Clin Exp Rheumatol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"458","DOI":"10.2223\/JPED.94","volume":"76","author":"Borsato M.L.","year":"2000","unstructured":"Borsato M.L.; Bruniera P.; Cusato M.P.; Spewien K.E.; Durigon E.L.; Toporovski J.; Aplastic crisis in sickle cell anemia induced by parvov\u00edrus B19. J Pediatr  2000,76(6),458-460","journal-title":"J Pediatr"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"799","DOI":"10.5858\/2007-131-799-PBIITI","volume":"131","author":"Florea A.V.","year":"2007","unstructured":"Florea A.V.; Ionescu D.N.; Melhem M.F.; Parvovirus B19 infection in the immunocompromised host. Arch Pathol Lab Med  2007,131(5),799-804","journal-title":"Arch Pathol Lab Med"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.pedhc.2021.05.006","volume":"36","author":"Grohall S.J.","year":"2022","unstructured":"Grohall S.J.; Colon A.A.; Churosh J.L.; Bryant R.; Zangwill S.D.; Parvovirus: From fifth disease to heart transplant. J Pediatr Health Care  2022,36(2),165-169","journal-title":"J Pediatr Health Care"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/rmv.388","volume":"13","author":"Barah F.","year":"2003","unstructured":"Barah F.; Vallely P.J.; Cleator G.M.; Kerr J.R.; Neurological manifestations of human parvovirus B19 infection. Rev Med Virol  2003,13(3),185-199","journal-title":"Rev Med Virol"},{"key":"ref=81","first-page":"271","volume":"62","author":"Boeck K.","year":"1998","unstructured":"Boeck K.; Mempel M.; Schmidt T.; Abeck D.; Gianotti-Crosti syndrome: Clinical, serologic, and therapeutic data from nine children. Cutis  1998,62(6),271-274","journal-title":"Cutis"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1086\/599042","volume":"48","author":"Douvoyiannis M.","year":"2009","unstructured":"Douvoyiannis M.; Litman N.; Goldman D.L.; Neurologic manifestations associated with parvovirus B19 infection. Clin Infect Dis  2009,48(12),1713-1723","journal-title":"Clin Infect Dis"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.annder.2010.06.023","volume":"137","author":"Dubois A.","year":"2010","unstructured":"Dubois A.; Thellier S.; Wierzbicka-Hainaut E.; Pierre F.; Anyfantakis V.; Guillet G.; Two cases of baboon-like exanthema in primary parvovi-rus B19 infection. Ann Dermatol Venereol  2010,137(11),709-712","journal-title":"Ann Dermatol Venereol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1007\/s00431-022-04406-x","volume":"181","author":"Esmel-Vilomara R.","year":"2022","unstructured":"Esmel-Vilomara R.; Dolader P.; Izquierdo-Blasco J.; Parvovirus B19 myocarditis in children: A diagnostic and therapeutic approach. Eur J Pediatr  2022,181(5),2045-2053","journal-title":"Eur J Pediatr"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1111\/pde.13623","volume":"35","author":"Ferrari B.","year":"2018","unstructured":"Ferrari B.; D\u00edaz M.S.; L\u00f3pez M.; Larralde M.; Unusual skin manifestations associated with parvovirus B19 primary infection in children. Pediatr Dermatol  2018,35(6),e341-e344","journal-title":"Pediatr Dermatol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/1359486","volume":"2017","author":"Furukawa M.","year":"2017","unstructured":"Furukawa M.; Kaji K.; Masuda H.; Severe Aplastic anemia following parvovirus B19-associated acute hepatitis. Case Reports Hepatol  2017,2017,1-5","journal-title":"Case Reports Hepatol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S0190-9622(99)70027-7","volume":"41","author":"Grilli R.","year":"1999","unstructured":"Grilli R.; Izquierdo M.J.; Fari\u00f1a M.C.; Papular-purpuric \u201cgloves and socks\u201d syndrome: Polymerase chain reaction demonstration of parvovirus B19 DNA in cutaneous lesions and sera. J Am Acad Dermatol  1999,41(5),793-796","journal-title":"J Am Acad Dermatol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1128\/JCM.00575-11","volume":"49","author":"Hatakka A.","year":"2011","unstructured":"Hatakka A.; Klein J.; He R.; Piper J.; Tam E.; Walkty A.; Acute hepatitis as a manifestation of parvovirus B19 infection. J Clin Microbiol  2011,49(9),3422-3424","journal-title":"J Clin Microbiol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1097\/01.inf.0000101783.73240.4a","volume":"22","author":"Kellermayer R.","year":"2003","unstructured":"Kellermayer R.; Faden H.; Grossi M.; Clinical presentation of parvovirus B19 infection in children with aplastic crisis. Pediatr Infect Dis J  2003,22(12),1100-1101","journal-title":"Pediatr Infect Dis J"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"e21726","DOI":"10.7759\/cureus.21726","volume":"14","author":"Keramari S.","year":"2022","unstructured":"Keramari S.; Poutoglidis A.; Chatzis S.; Keramaris M.; Savopoulos C.; Kaiafa G.; Parvovirus B19-associated myocarditis: A literature review of pediatric cases. Cureus  2022,14(1),e21726","journal-title":"Cureus"},{"key":"ref=91","first-page":"814","volume":"43","author":"Kishore J.","year":"2006","unstructured":"Kishore J.; Singh J.; Detection of parvovirus B19 in a case of erythema infectiosum with myositis. Indian Pediatr  2006,43(9),814-817","journal-title":"Indian Pediatr"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2431-14-6","volume":"14","author":"Koliou M.","year":"2014","unstructured":"Koliou M.; Karaoli E.; Soteriades E.S.; Pavlides S.; Bashiardes S.; Christodoulou C.; Acute hepatitis and myositis associated with Erythema infectiosum by Parvovirus B19 in an adolescent. BMC Pediatr  2014,14(1),6","journal-title":"BMC Pediatr"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1001\/jamadermatol.2018.2932","volume":"154","author":"Kreuter A.","year":"2018","unstructured":"Kreuter A.; Koushk Jalali B.; Tigges C.; Silling S.; Lehmann P.; Wieland U.; Juvenile spring eruption associated with parvovirus B19 infection. JAMA Dermatol  2018,154(11),1356-1357","journal-title":"JAMA Dermatol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00059-012-3656-3","volume":"37","author":"K\u00fchl U.","year":"2012","unstructured":"K\u00fchl U.; Rohde M.; Lassner D.; Gross U.M.; Escher F.; Schultheiss H.P.; miRNA as activity markers in Parvo B19 associated heart disease. Herz  2012,37(6),637-643","journal-title":"Herz"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jpeds.2015.06.042","volume":"167","author":"Leung A.K.C.","year":"2015","unstructured":"Leung A.K.C.; Barankin B.; Unilateral laterothoracic exanthem. J Pediatr  2015,167(3),775","journal-title":"J Pediatr"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1002\/art.1780341018","volume":"34","author":"Leventhal L.J.","year":"1991","unstructured":"Leventhal L.J.; Naides S.J.; Freundlich B.; Fibromyalgia and parvovirus infection. Arthritis Rheum  1991,34(10),1319-1324","journal-title":"Arthritis Rheum"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1099\/jgv.0.000621","volume":"97","author":"Naciute M.","year":"2016","unstructured":"Naciute M.; Mieliauskaite D.; Rugiene R.; Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis. J Gen Virol  2016,97(12),3302-3312","journal-title":"J Gen Virol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1572-0241.1998.468_1.x","volume":"93","author":"Pardi D.S.","year":"1998","unstructured":"Pardi D.S.; Romero Y.; Mertz L.E.; Douglas D.D.; Hepatitis-associated aplastic anemia and acute parvovirus B19 infection: A report of two cases and a review of the literature. Am J Gastroenterol  1998,93(3),468-470","journal-title":"Am J Gastroenterol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1590\/S0100-879X2001000900005","volume":"34","author":"Pinho J.R.R.","year":"2001","unstructured":"Pinho J.R.R.; Alves V.A.F.; Vieira A.F.; Detection of human parvovirus B19 in a patient with hepatitis. Braz J Med Biol Res  2001,34(9),1131-1138","journal-title":"Braz J Med Biol Res"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1007\/s13365-017-0562-8","volume":"23","author":"Sequeira J.","year":"2017","unstructured":"Sequeira J.; Calado A.; Dias M.; Manita M.; Parvovirus B19 infection associated with hemolytic anemia and cranial polyneuropathy. J Neurovirol  2017,23(5),786-788","journal-title":"J Neurovirol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1159\/000046086","volume":"89","author":"Takeda S.","year":"2001","unstructured":"Takeda S.; Takaeda C.; Takazakura E.; Haratake J.; Renal involvement induced by human parvovirus B19 infection. Nephron J  2001,89(3),280-285","journal-title":"Nephron J"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"9808205","DOI":"10.3389\/fmed.2022.808205","author":"Zou Q.","year":"2022","unstructured":"Zou Q.; Chen P.; Chen J.; Multisystem involvement induced by human parvovirus B19 infection in a non-immunosuppressed adult: A case report. Front Med  2022,9808205","journal-title":"Front Med"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1080\/08880010490457141","volume":"21","author":"Aktepe O.C.","year":"2004","unstructured":"Aktepe O.C.; Yetgin S.; Olcay L.; \u00d6zbek N.; Human parvovirus B19 associated with idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol  2004,21(5),421-426","journal-title":"Pediatr Hematol Oncol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1080\/00365549850161188","volume":"30","author":"Heegaard E.D.","year":"1998","unstructured":"Heegaard E.D.; Eiskjaer H.; Baandrup U.; Hornsleth A.; Parvovirus B19 infection associated with myocarditis following adult cardiac transplantation. Scand J Infect Dis  1998,30(6),607-609","journal-title":"Scand J Infect Dis"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(94)92152-0","volume":"343","author":"Finkel T.H.","year":"1994","unstructured":"Finkel T.H.; Leung D.Y.M.; Harbeck R.J.; Chronic parvovirus B19 infection and systemic necrotising vasculitis: Opportunistic infection or aetiological agent? Lancet  1994,343(8908),1255-1258","journal-title":"Lancet"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.semnephrol.2008.08.010","volume":"28","author":"Waldman M.","year":"2008","unstructured":"Waldman M.; Marshall V.; Whitby D.; Kopp J.B.; Viruses and kidney disease: Beyond HIV. Semin Nephrol  2008,28(6),595-607","journal-title":"Semin Nephrol"},{"key":"ref=107","first-page":"1195","volume":"55","author":"Staroselsky A.","year":"2009","unstructured":"Staroselsky A.; Klieger-Grossmann C.; Garcia-Bournissen F.; Koren G.; Exposure to fifth disease in pregnancy. Can Fam Physician  2009,55(12),1195-1198","journal-title":"Can Fam Physician"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1056\/NEJM198701223160403","volume":"316","author":"Anand A.","year":"1987","unstructured":"Anand A.; Gray E.S.; Brown T.; Clewley J.P.; Cohen B.J.; Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med  1987,316(4),183-186","journal-title":"N Engl J Med"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3390\/medicina58050664","volume":"58","author":"Kielaite D.","year":"2022","unstructured":"Kielaite D.; Paliulyte V.; Parvovirus (B19) infection during pregnancy: Possible effect on the course of pregnancy and rare fetal outcomes. A case report and literature review. Medicina  2022,58(5),664","journal-title":"Medicina"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2174\/1573396314666180820154340","volume":"14","author":"Kontomanolis E.N.","year":"2018","unstructured":"Kontomanolis E.N.; Fasoulakis Z.; Hydrops fetalis and the Parvovirus B-19. Curr Pediatr Rev  2018,14(4),239-252","journal-title":"Curr Pediatr Rev"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1552-6909.2002.tb00029.x","volume":"31","author":"McCarter-Spaulding D.","year":"2002","unstructured":"McCarter-Spaulding D.; Parvovirus B19 in Pregnancy. J Obstet Gynecol Neonatal Nurs  2002,31(1),107-112","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/(SICI)1097-0223(199604)16:4<342:AID-PD851>3.0.CO;2-F","volume":"16","author":"Petrikovsky B.M.","year":"1996","unstructured":"Petrikovsky B.M.; Baker D.; Schneider E.; Fetal hydrops secondary to human parvovirus infection in early pregnancy. Prenat Diagn  1996,16(4),342-344","journal-title":"Prenat Diagn"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/S0140-6736(88)92684-0","volume":"332","author":"Schwarz T.","year":"1988","unstructured":"Schwarz T.; Roggendorf M.; Hottentr\u00e4ger B.; Human parvovirus B19 infection in pregnancy. Lancet  1988,332(8610),566-567","journal-title":"Lancet"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3122\/jabfm.16.1.63","volume":"16","author":"Xu J.","year":"2003","unstructured":"Xu J.; Raff T.C.; Muallem N.S.; Neubert A.G.; Hydrops fetalis secondary to parvovirus B19 infections. J Am Board Fam Med  2003,16(1),63-68","journal-title":"J Am Board Fam Med"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/pd.940","volume":"24","author":"Enders M.","year":"2004","unstructured":"Enders M.; Weidner A.; Zoellner I.; Searle K.; Enders G.; Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: Prospective evaluation of 1018 cases. Prenat Diagn  2004,24(7),513-518","journal-title":"Prenat Diagn"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1086\/593190","volume":"47","author":"Riipinen A.","year":"2008","unstructured":"Riipinen A.; V\u00e4is\u00e4nen E.; Nuutila M.; Parvovirus b19 infection in fetal deaths. Clin Infect Dis  2008,47(12),1519-1525","journal-title":"Clin Infect Dis"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0002-8703(97)70259-X","volume":"133","author":"Barton L.L.","year":"1997","unstructured":"Barton L.L.; Lax D.; Shehab Z.M.; Keith J.C.; Congenital cardiomyopathy associated with human parvovirus B19 infection. Am Heart J  1997,133(1),131-133","journal-title":"Am Heart J"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/uog.19092","volume":"52","author":"Bascietto F.","year":"2018","unstructured":"Bascietto F.; Liberati M.; Murgano D.; Outcome of fetuses with congenital parvovirus B19 infection: Systematic review and meta-analysis. Ultrasound Obstet Gynecol  2018,52(5),569-576","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"204.e1","DOI":"10.1016\/j.ajog.2011.12.035","volume":"206","author":"De Jong E.P.","year":"2012","unstructured":"De Jong E.P.; Lindenburg I.T.; van Klink J.M.; Intrauterine transfusion for parvovirus B19 infection: Long-term neurodevelopmental outcome. Am J Obstet Gynecol  2012,206(3),204.e1-204.e5","journal-title":"Am J Obstet Gynecol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1055\/s-2007-994201","volume":"13","author":"Katz V.","year":"1996","unstructured":"Katz V.; McCoy M.; Kuller J.; Hansen W.; An association between fetal parvovirus B19 infection and fetal anomalies: A report of two cases. Am J Perinatol  1996,13(1),43-45","journal-title":"Am J Perinatol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/pd.1970140305","volume":"14","author":"Tiessen R.G.","year":"1994","unstructured":"Tiessen R.G.; van Elsacker-Niele A.M.W.; Vermeij-Keers C.; Oepkes D.; van Roosmalen J.; Gorsira M.C.B.; A fetus with a parvovirus B19 infection and congenital anomalies. Prenat Diagn  1994,14(3),173-176","journal-title":"Prenat Diagn"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S0140-6736(87)90442-9","volume":"329","author":"Weiland H.T.","year":"1987","unstructured":"Weiland H.T.; Vermey-Keers C.; Salimans M.M.M.; Fleuren G.J.; Verwey R.A.; Anderson M.J.; Parvovirus B19 associated with fetal abnormality. Lancet  1987,329(8534),682-683","journal-title":"Lancet"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.reprotox.2005.01.006","volume":"21","author":"Ergaz Z.","year":"2006","unstructured":"Ergaz Z.; Ornoy A.; Parvovirus B19 in pregnancy. Reprod Toxicol  2006,21(4),421-435","journal-title":"Reprod Toxicol"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1093\/infdis\/157.4.663","volume":"157","author":"Kinney J.S.","year":"1988","unstructured":"Kinney J.S.; Anderson L.J.; Farrar J.; Risk of adverse outcomes of pregnancy after human parvovirus B19 infection. J Infect Dis  1988,157(4),663-667","journal-title":"J Infect Dis"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1471-0528.1998.tb10048.x","volume":"105","author":"Miller E.","year":"1998","unstructured":"Miller E.; Fairley C.K.; Cohen B.J.; Seng C.; Immediate and long term outcome of human parvovirus B19 infection in pregnancy. BJOG  1998,105(2),174-178","journal-title":"BJOG"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"127","DOI":"10.12809\/hkmj198287","volume":"26","author":"Leung K.K.Y.","year":"2020","unstructured":"Leung K.K.Y.; Hon K.L.; Yeung A.; Leung A.K.C.; Man E.; Congenital infections in Hong Kong: An overview of TORCH. Hong Kong Med J  2020,26(2),127-138","journal-title":"Hong Kong Med J"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"318","DOI":"10.12809\/hkmj208398","volume":"26","author":"Hon K.L.","year":"2020","unstructured":"Hon K.L.; Leung K.K.Y.; Leung A.K.C.; Man E.; Ip P.; Congenital infections in Hong Kong: Beyond TORCH. Hong Kong Med J  2020,26(4),318-322","journal-title":"Hong Kong Med J"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0212-6567(00)78636-7","volume":"26","author":"Revilla Grande A.I.","year":"2000","unstructured":"Revilla Grande A.I.; Carro Garc\u00eda T.; S\u00e1nchez de Dios M.; Gal\u00e1n Calvo M.J.; Nebreda Mayoral T.; Outbreak of infectious erythema at a urban health center. Aten Primaria  2000,26(3),172-175","journal-title":"Aten Primaria"}],"container-title":["Current Pediatric Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573396320666230428104619","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/216328\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573396320666230428104619","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T06:56:47Z","timestamp":1724137007000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/216328\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":128,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573396320666230428104619","relation":{},"ISSN":["1573-3963"],"issn-type":[{"value":"1573-3963","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-09-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}